Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-01 @ 4:53 PM
Study NCT ID:
NCT06329869
Status:
RECRUITING
Last Update Posted:
2024-12-02
First Post:
2024-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
Sponsor:
National Taiwan University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-17
First Submit QC Date:
None
Study First Post Date:
2024-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-27
Last Update Post Date:
2024-12-02
Last Update Post Date Type:
ACTUAL